Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.Verani JR Baqui AH Broome CV Cherian T Cohen C Farrar JL Feikin DR Groome MJ Hajjeh RA Johnson HL Madhi SA Mulholland K O'Brien KL Parashar UD Patel MM Rodrigues LC Santosham M Scott JA Smith PG Sommerfelt H Tate JE Victor JC Whitney CG Zaidi AK Zell ER
Vaccine, (2017). 35:3295-3302

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.Verani JR Baqui AH Broome CV Cherian T Cohen C Farrar JL Feikin DR Groome MJ Hajjeh RA Johnson HL Madhi SA Mulholland K O'Brien KL Parashar UD Patel MM Rodrigues LC Santosham M Scott JA Smith PG Sommerfelt H Tate JE Victor JC Whitney CG Zaidi AK Zell ER
Vaccine, (2017). 35:3303-3308

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.Nyiro JU Sande C Mutunga M Kiyuka PK Munywoki PK Scott JA Nokes DJ
Vaccine, (2015). 33:1797-801

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.Satzke C Turner P Virolainen-Julkunen A Adrian PV Antonio M Hare KM Henao-Restrepo AM Leach AJ Klugman KP Porter BD Sa-Leao R Scott JA Nohynek H O'Brien KL WHOPneumococcal Carriage Working Group
Vaccine, (2013). 32:165-79

Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?.Moisi JC Kabuka J Mitingi D Levine OS Scott JA
Vaccine, (2010). 28:5725-30

The preventable burden of pneumococcal disease in the developing world.Scott JA
Vaccine, (2007). 25:2398-405